Skip to content

Intalect

A regional UK MSSP acquired by Manchester-based Novem as Novem's fifth acquisition since 2023 (backed by Independence Capital), continuing a deliberate national roll-up strategy in IT and cybersecurity services.

+ Add to Compare
27/100Emerging / Unranked

Innovation Matrix Assessment

Innovation Velocity 2/10

No specific product or technology innovation was disclosed beyond standard regional MSSP service delivery.

Operational Value 3/10

Established regional managed security services provider in Leicestershire prior to acquisition.

Market Momentum 3/10

Acquired by Novem in May 2026 as Novem's fifth acquisition since 2023, part of an active UK roll-up strategy.

Category Disruption 2/10

Regional MSSP services are a mature, fragmented category with no unique technology differentiation disclosed.

Real-World Efficacy 2/10

No independently verifiable customer names or outcome data were found for Intalect specifically.

Enduring Relevance 4/10

Regional managed security services remain a steady, ongoing need for smaller UK businesses without in-house SOC capacity.

Why CISOs Should Care

Intalect gives Leicestershire and surrounding UK businesses a local managed security services partner, an alternative to national providers for organizations that value regional relationships and support.

What Makes It Different

Intalect operates as a regional MSSP in Leicestershire, giving it local market knowledge and relationships that a larger national or international provider would need years to replicate.

The Matrix Verdict

27/100 — EMERGING / UNRANKED

A regional UK MSSP acquired by Manchester-based Novem as Novem's fifth acquisition since 2023 (backed by Independence Capital), continuing a deliberate national roll-up strategy in IT and cybersecurity services.

Editorial Note: Claims vs. Verified Findings

The 'fifth acquisition since 2023' detail and Independence Capital backing are reported directly by the covering outlet (MSN/citing local business press); no revenue or customer figures for Intalect specifically were disclosed.

Sources